Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.

Item
http://www.wikidata.org/entity/Q34227776
Impact of protein kinase CK2 inhibitors on proliferation and differentiation of neural stem cells.Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyCK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways.Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.Casein kinases as potential therapeutic targets.Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures.Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity.Therapeutic targeting of CK2 in acute and chronic leukemias.Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling CascadeCX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism
P2860

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.

Item
http://www.wikidata.org/entity/Q34227776
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@ast
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@en
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@nl
type
label
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@ast
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@en
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@nl
prefLabel
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@ast
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@en
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Therapeutic CK2 inhibition att ...... in human breast cancer cells.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932